|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
84,540,000 |
Market
Cap: |
346.61(M) |
Last
Volume: |
34,905,322 |
Avg
Vol: |
12,169,916 |
52
Week Range: |
$4.1 - $4.1 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-03-28 |
2023-12-26 |
2023-06-27 |
2022-06-27 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Israel Robert J |
Sr. VP, Medical Affairs |
|
2005-10-03 |
4 |
OE |
$16.81 |
$13,246 |
D/D |
788 |
21,133 |
|
- |
|
Israel Robert J |
Sr. VP, Medical Affairs |
|
2005-09-13 |
4 |
AS |
$25.00 |
$75,000 |
D/D |
(3,000) |
20,155 |
|
- |
|
Israel Robert J |
Sr. VP, Medical Affairs |
|
2005-09-12 |
4 |
AS |
$25.00 |
$50,000 |
D/D |
(2,000) |
23,155 |
|
- |
|
Mckinney Robert A |
Chief Financial Officer |
|
2005-08-01 |
4 |
AS |
$23.35 |
$281,100 |
D/D |
(12,000) |
18,284 |
|
- |
|
Mckinney Robert A |
Chief Financial Officer |
|
2005-08-01 |
4 |
OE |
$4.00 |
$48,000 |
D/D |
12,000 |
20,284 |
|
- |
|
Scheinberg David A |
Director |
|
2005-07-11 |
4 |
GA |
$0.00 |
$0 |
D/D |
468 |
24,181 |
|
- |
|
Scheinberg David A |
Director |
|
2005-07-11 |
4 |
OE |
$23.00 |
$46,000 |
D/D |
2,000 |
23,713 |
|
- |
|
Scheinberg David A |
Director |
|
2005-07-11 |
4 |
OE |
$4.00 |
$8,000 |
D/D |
2,000 |
25,713 |
|
- |
|
Baker Mark Robert |
General Counsel |
|
2005-07-01 |
4 |
A |
$17.73 |
$17,500 |
D/D |
987 |
1,487 |
|
- |
|
Boyd Thomas A |
Sr. VP, Product Dev. |
|
2005-07-01 |
4 |
A |
$0.00 |
$2,488 |
D/D |
7,645 |
20,071 |
|
- |
|
Kremer Alton B |
VP, Clinical Research |
|
2005-07-01 |
4 |
A |
$0.00 |
$3,209 |
D/D |
3,687 |
6,486 |
|
- |
|
Olson William C |
VP, Research & Development |
|
2005-07-01 |
4 |
A |
$0.00 |
$2,728 |
D/D |
4,659 |
17,770 |
|
- |
|
Mckinney Robert A |
Chief Financial Officer |
|
2005-07-01 |
4 |
A |
$0.00 |
$2,728 |
D/D |
4,659 |
18,284 |
|
- |
|
Scheinberg David A |
Director |
|
2005-07-01 |
4 |
S |
$20.85 |
$41,700 |
D/D |
(2,000) |
23,713 |
|
- |
|
Scheinberg David A |
Director |
|
2005-07-01 |
4 |
OE |
$4.00 |
$8,000 |
D/D |
2,000 |
25,713 |
|
- |
|
Maddon Paul J |
Chief Executive Officer/CSO |
|
2005-07-01 |
4 |
A |
$0.00 |
$8,443 |
D/D |
25,492 |
586,047 |
|
- |
|
Israel Robert J |
Sr. VP, Medical Affairs |
|
2005-07-01 |
4 |
A |
$0.00 |
$3,054 |
D/D |
3,678 |
25,155 |
|
- |
|
Olson William C |
VP, Research and Development |
|
2005-06-21 |
4 |
S |
$20.00 |
$13,000 |
D/D |
(650) |
13,111 |
|
- |
|
Maddon Paul J |
CEO & CSO |
|
2005-06-21 |
4 |
S |
$20.00 |
$125,163 |
D/D |
(6,250) |
599,303 |
|
- |
|
Baker Mark Robert |
GNL COUNSELOfficer |
|
2005-06-20 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
500 |
|
- |
|
Boyd Thomas A |
SR. VP, Product Development |
|
2005-06-20 |
4 |
S |
$19.85 |
$14,888 |
D/D |
(750) |
12,426 |
|
- |
|
Mckinney Robert A |
Cheif Financial Officer |
|
2005-06-20 |
4 |
S |
$19.87 |
$14,903 |
D/D |
(750) |
13,625 |
|
- |
|
Jacobson Paul F |
Co-Chairman |
|
2005-06-20 |
4 |
S |
$19.85 |
$59,550 |
D/D |
(3,000) |
188,100 |
|
- |
|
Israel Robert J |
SR. VP Medical Affairs |
|
2005-06-20 |
4 |
S |
$19.87 |
$14,903 |
D/D |
(750) |
21,477 |
|
- |
|
Goff Stephen P |
Director |
|
2005-06-20 |
4 |
S |
$19.85 |
$59,550 |
D/D |
(3,000) |
33,500 |
|
- |
|
801 Records found
|
|
Page 27 of 33 |
|
|